BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi ST, Yang GY, Wang LD, Xue Z, Feng B, Ding W, Xing EP, Yang CS. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis. 1999;20:591-597. [PMID: 10223186 DOI: 10.1093/carcin/20.4.591] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Casson AG, Schrump DS. BIOLOGY AND EPIDEMIOLOGY OF MALIGNANT ESOPHAGEAL CARCINOMA. Pearson's Thoracic and Esophageal Surgery. Elsevier; 2008. pp. 439-53. [DOI: 10.1016/b978-0-443-06861-4.50191-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Li LY, Tang JT, Jia LQ, Li PW. Mutations of p53 gene exons 4-8 in human esophageal cancer. World J Gastroenterol 2005; 11(19): 2998-3001 [PMID: 15902745 DOI: 10.3748/wjg.v11.i19.2998] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Chang K, Sarraj S, Lin S, Tsai P, Solt D. p53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000;21:1441-51. [DOI: 10.1093/carcin/21.5.441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Yang Y, Tarapore RS, Jarmel MH, Tetreault MP, Katz JP. p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation. Cell Cycle 2012;11:4033-9. [PMID: 22990386 DOI: 10.4161/cc.22265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
5 Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003; 9(1): 16-21 [PMID: 12508343 DOI: 10.3748/wjg.v9.i1.16] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
6 Makino R, Kaneko K, Kurahashi T, Matsumura T, Mitamura K. Detection of mutation of the p53 gene with high sensitivity by fluorescence-based PCR-SSCP analysis using low-pH buffer and an automated DNA sequencer in a large number of DNA samples. Mutat Res. 2000;452:83-90. [PMID: 10894894 DOI: 10.1016/S0027-5107(00)00056-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 Mir MM, Dar NA, Gochhait S, Zargar SA, Ahangar AG, Bamezai RN. p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int J Cancer. 2005;116:62-68. [PMID: 15761872 DOI: 10.1002/ijc.21002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
8 Figueroa JD, Terry MB, Gammon MD, Vaughan TL, Risch HA, Zhang FF, Kleiner DE, Bennett WP, Howe CL, Dubrow R, Mayne ST, Fraumeni JF Jr, Chow WH. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes Control 2009;20:361-8. [PMID: 18989634 DOI: 10.1007/s10552-008-9250-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
9 Ito S, Ohga T, Saeki H, Nakamura T, Watanabe M, Tanaka S, Kakeji Y, Maehara Y. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. Int J Cancer 2005;113:22-8. [PMID: 15386362 DOI: 10.1002/ijc.20500] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
10 Tanière P, Martel-Planche G, Puttawibul P, Casson A, Montesano R, Chanvitan A, Hainaut P. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand. Int J Cancer 2000;88:223-7. [PMID: 11004672 DOI: 10.1002/1097-0215(20001015)88:2<223::aid-ijc12>3.0.co;2-g] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Choi H, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-naggar AK. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Human Pathology 2002;33:158-64. [DOI: 10.1053/hupa.2002.30722] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 4.3] [Reference Citation Analysis]
12 Chang K, Sarraj S, Lin S, Tsai P, Solt D. p53 expression, p53 and Ha- ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000;21:1441-51. [DOI: 10.1093/carcin/21.7.1441] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shi W, Wang Q, Bian Y, Fan Y, Zhou Y, Feng T, Li Z, Cao X. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA. Pathology - Research and Practice 2019;215:152604. [DOI: 10.1016/j.prp.2019.152604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Tarazi M, Chidambaram S, Markar SR. Risk Factors of Esophageal Squamous Cell Carcinoma beyond Alcohol and Smoking. Cancers (Basel) 2021;13:1009. [PMID: 33671026 DOI: 10.3390/cancers13051009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res. 2000;462:335-342. [PMID: 10767643 DOI: 10.1016/s1383-5742(00)00019-3] [Cited by in Crossref: 139] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
16 Elfaki RM, Abdelaziz MS, Altayb HN, Munsoor MM, Gameel AA. Molecular and in-silico analysis of single nucleotide polymorphism targeting human TP53 gene exon 5-8 in Sudanese esophageal cancer patients. F1000Res 2018;7:1741. [PMID: 31316750 DOI: 10.12688/f1000research.15534.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol. 2001;32:1157-1165. [PMID: 11727253 DOI: 10.1053/hupa.2001.28951] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 4.2] [Reference Citation Analysis]
18 Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015;110:662-682; quiz 683. [PMID: 25869390 DOI: 10.1038/ajg.2015.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 11.4] [Reference Citation Analysis]
19 Schreurs LMA, Smit JK, Pavlov K, Pultrum BB, Pruim J, Groen H, Hollema H, Plukker JTM. Prognostic Impact of Clinicopathological Features and Expression of Biomarkers Related to 18F-FDG Uptake in Esophageal Cancer. Ann Surg Oncol 2014;21:3751-7. [DOI: 10.1245/s10434-014-3848-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
20 Silva-Silva RA, Romero-Amaro ZR, Linares-Larrazabal LA, Arismendi-Morillo GJ. Multiple and synchronous squamous cell carcinoma of the esophagus in a young woman: An example of early and rapid carcinogenesis? Rev Gastroenterol Mex 2016;81:176-8. [PMID: 26949194 DOI: 10.1016/j.rgmx.2015.09.005] [Reference Citation Analysis]
21 Robert V, Michel P, Flaman JM, Chiron A, Martin C, Charbonnier F, Paillot B, Frebourg T. High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis. 2000;21:563-565. [PMID: 10753186 DOI: 10.1093/carcin/21.4.563] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 1.5] [Reference Citation Analysis]
22 Ebihara Y, Miyamoto M, Fukunaga A, Kato K, Shichinohe T, Kawarada Y, Kurokawa T, Cho Y, Murakami S, Uehara H, Kaneko H, Hashimoto H, Murakami Y, Itoh T, Okushiba S, Kondo S, Katoh H. DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma. Br J Cancer 2004;91:119-23. [PMID: 15188007 DOI: 10.1038/sj.bjc.6601899] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
23 Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z, Zhang X, Niu Y, Shen Z, Shen J, Wu X, Li E. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 2007;60:555-61. [PMID: 17412867 DOI: 10.1136/jcp.2006.039297] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
24 Wen L, Xu F, He X, Wang K, He D, Qing T, Zou Z. Application Progress of Exonuclease-Assisted Signal Amplification Strategies in Biochemical Analysis. Chinese Journal of Analytical Chemistry 2015;43:1620-8. [DOI: 10.1016/s1872-2040(15)60874-x] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 Goan Y, Chang H, Hsu H, Chou Y, Cheng J. Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese. Cancer Science 2005;96:758-65. [DOI: 10.1111/j.1349-7006.2005.00115.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
26 Rossini A, de Almeida Simão T, Marques CB, Soares-Lima SC, Herbster S, Rapozo DC, Andreollo NA, Ferreira MA, El-Jaick KB, Teixeira R, Guimarães DP, Albano RM, Ribeiro Pinto LF. TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil. Mutat Res 2010;696:10-5. [PMID: 19944185 DOI: 10.1016/j.mrgentox.2009.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
27 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(9): 2222-2225 [DOI: 10.11569/wcjd.v12.i9.2222] [Reference Citation Analysis]
28 Xing Y, Ning Y, Ru LQ, Wang LD. Expressions of PCNA, p53, p21WAF-1 and cell proliferation in fetal esophageal epithelia: Comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China. World J Gastroenterol 2003; 9(7): 1601-1603 [PMID: 12854173 DOI: 10.3748/wjg.v9.i7.1601] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Sepehr A, Tanière P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene. 2001;20:7368-7374. [PMID: 11704866 DOI: 10.1038/sj.onc.1204912] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
30 Nishikawa T, Salim EI, Morimura K, Kaneko M, Ogawa M, Kinoshita A, Osugi H, Kinoshita H, Fukushima S. High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine. Cancer Letters 2003;194:45-54. [DOI: 10.1016/s0304-3835(03)00057-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Egashira A, Morita M, Yoshida R, Saeki H, Oki E, Sadanaga N, Kakeji Y, Tsujitani S, Maehara Y. Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients. J Surg Oncol. 2011;104:169-175. [PMID: 21462189 DOI: 10.1002/jso.21920] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
32 Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 2003; 9(6): 1156-1164 [PMID: 12800215 DOI: 10.3748/wjg.v9.i6.1156] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
33 Peng J, Hu Q, Liu W, He X, Cui L, Chen X, Yang M, Liu H, Wei W, Liu S. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Diagn Pathol. 2013;8:177. [PMID: 24152793 DOI: 10.1186/1746-1596-8-177] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
34 Xu XC. Risk factors and gene expression in esophageal cancer. Methods Mol Biol. 2009;471:335-360. [PMID: 19109788 DOI: 10.1007/978-1-59745-416-2_17] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
35 Yasuda M, Kuwano H, Watanabe M, Toh Y, Ohno S, Sugimachi K. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Br J Cancer. 2000;83:1033-1038. [PMID: 10993651 DOI: 10.1054/bjoc.2000.1443] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
36 Qi Y, Chiu JF, Wang L, Kwong DL, He QY. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics. 2005;5:2960-2971. [PMID: 15986332 DOI: 10.1002/pmic.200401175] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 6.2] [Reference Citation Analysis]
37 Singhi AD, Arnold CA, Lam-himlin DM, Nikiforova MN, Voltaggio L, Canto MI, Mcgrath KM, Montgomery EA. Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia. Mod Pathol 2017;30:1613-21. [DOI: 10.1038/modpathol.2017.73] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
38 Egashira A, Morita M, Kakeji Y, Sadanaga N, Oki E, Honbo T, Ohta M, Maehara Y. p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. Cancer Sci 2007;98:1152-6. [PMID: 17573896 DOI: 10.1111/j.1349-7006.2007.00524.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
39 Kaneko K, Katagiri A, Konishi K, Kurahashi T, Ito H, Kumekawa Y, Yamamoto T, Muramoto T, Kubota Y, Nozawa H, Makino R, Kushima M, Imawari M. Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. Br J Cancer 2007;96:492-8. [PMID: 17285122 DOI: 10.1038/sj.bjc.6603582] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
40 Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. p53 gene mutation and protein accumulation during neoplastic progression in Barrett’s esophagus. Mod Pathol. 2001;14:397-403. [PMID: 11353048 DOI: 10.1038/modpathol.3880324] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 3.2] [Reference Citation Analysis]
41 Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, Li E. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006;59:958-64. [PMID: 16524962 DOI: 10.1136/jcp.2005.032730] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
42 Plum PS, Bollschweiler E, Hölscher AH, Warnecke-Eberz U. Novel diagnostic and prognostic biomarkers in esophageal cancer. Expert Opin Med Diagn 2013;7:557-71. [PMID: 24093836 DOI: 10.1517/17530059.2013.843526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
43 Kaneko K, Murakami Y, Katagiri A, Konishi K, Kubota Y, Muramoto T, Kushima M, Ohtsu A, Imawari M. Does daily alcohol and/or cigarette consumption cause low-grade dysplasia, a precursor of esophageal squamous cell carcinoma? J Clin Gastroenterol. 2010;44:173-179. [PMID: 19826274 DOI: 10.1097/MCG.0b013e3181bb837a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
44 Qi YJ, He QY, Ma YF, Du YW, Liu GC, Li YJ, Tsao GS, Ngai SM, Chiu JF. Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. J Cell Biochem. 2008;104:1625-1635. [PMID: 18320592 DOI: 10.1002/jcb.21727] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
45 Boller D, Spieler P, Schoenegg R, Neuweiler J, Kradolfer D, Studer R, Grossenbacher R, Zuercher U, Meyenberger C, Borovicka J. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma. Surg Endosc 2009;23:2748-54. [PMID: 19444514 DOI: 10.1007/s00464-009-0489-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
46 Fang MZ, Liu C, Song Y, Yang GY, Nie Y, Liao J, Zhao X, Shimada Y, Wang LD, Yang CS. Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas. Carcinogenesis. 2004;25:865-871. [PMID: 14764456 DOI: 10.1093/carcin/bgh097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
47 Ishikawa M, Kitayama J, Kohno K, Nagawa H. The expression pattern of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus. Pathobiology 2005;72:139-45. [PMID: 15860931 DOI: 10.1159/000084117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]